(3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid

C79H105N17O27 — CID 118054343

IUPAC(3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid
SMILESCCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N2C(c3ccccc3O)OC[C@H]2C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C
InChIInChI=1S/C79H105N17O27/c1-5-6-7-8-9-10-11-26-59(100)88-49(29-42-35-83-47-23-16-13-19-43(42)47)72(115)90-50(31-58(82)99)73(116)92-53(34-65(109)110)74(117)95-67-41(4)123-79(121)54(30-57(98)44-20-12-15-22-46(44)81)93-77(120)66(39(2)28-62(103)104)94-75(118)55-38-122-78(45-21-14-17-25-56(45)97)96(55)61(102)37-85-69(112)51(32-63(105)106)89-68(111)40(3)86-71(114)52(33-64(107)108)91-70(113)48(24-18-27-80)87-60(101)36-84-76(67)119/h12-17,19-23,25,35,39-41,48-55,66-67,78,83,97H,5-11,18,24,26-34,36-38,80-81H2,1-4H3,(H2,82,99)(H,84,119)(H,85,112)(H,86,114)(H,87,101)(H,88,100)(H,89,111)(H,90,115)(H,91,113)(H,92,116)(H,93,120)(H,94,118)(H,95,117)(H,103,104)(H,105,106)(H,107,108)(H,109,110)/t39-,40-,41-,48+,49+,50-,51+,52+,53+,54+,55+,66+,67+,78?/m1/s1
InChIKeyXPXAOZHQFNGNGK-WMBILTDQSA-N
MW1724.80 g/mol
LogP-3.47
Rot. Bonds35

About (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid

(3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid (PubChem CID 118054343) has the molecular formula C79H105N17O27 and a molecular weight of 1724.80 g/mol. Its IUPAC name is (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid.

Molecular Properties

Compound Name(3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid
PubChem CID118054343
Molecular FormulaC79H105N17O27
Molecular Weight1724.80 g/mol
Exact Mass1723.74
IUPAC Name(3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid
SMILESCCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N2C(c3ccccc3O)OC[C@H]2C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C
InChIInChI=1S/C79H105N17O27/c1-5-6-7-8-9-10-11-26-59(100)88-49(29-42-35-83-47-23-16-13-19-43(42)47)72(115)90-50(31-58(82)99)73(116)92-53(34-65(109)110)74(117)95-67-41(4)123-79(121)54(30-57(98)44-20-12-15-22-46(44)81)93-77(120)66(39(2)28-62(103)104)94-75(118)55-38-122-78(45-21-14-17-25-56(45)97)96(55)61(102)37-85-69(112)51(32-63(105)106)89-68(111)40(3)86-71(114)52(33-64(107)108)91-70(113)48(24-18-27-80)87-60(101)36-84-76(67)119/h12-17,19-23,25,35,39-41,48-55,66-67,78,83,97H,5-11,18,24,26-34,36-38,80-81H2,1-4H3,(H2,82,99)(H,84,119)(H,85,112)(H,86,114)(H,87,101)(H,88,100)(H,89,111)(H,90,115)(H,91,113)(H,92,116)(H,93,120)(H,94,118)(H,95,117)(H,103,104)(H,105,106)(H,107,108)(H,109,110)/t39-,40-,41-,48+,49+,50-,51+,52+,53+,54+,55+,66+,67+,78?/m1/s1
InChIKeyXPXAOZHQFNGNGK-WMBILTDQSA-N
XLogP-3.47
TPSA702.46 Ų
H-Bond Donors21
H-Bond Acceptors25
Rotatable Bonds35
Heavy Atoms123
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001724.80
LogP ≤ 5-3.47
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'mannich_A(296)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid?
The IUPAC name of (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid (CID 118054343) is (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid.
What is the SMILES notation for (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid?
The canonical SMILES for (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid is CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N2C(c3ccccc3O)OC[C@H]2C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C.
What is the InChIKey of (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid?
The InChIKey is XPXAOZHQFNGNGK-WMBILTDQSA-N. The full InChI is InChI=1S/C79H105N17O27/c1-5-6-7-8-9-10-11-26-59(100)88-49(29-42-35-83-47-23-16-13-19-43(42)47)72(115)90-50(31-58(82)99)73(116)92-53(34-65(109)110)74(117)95-67-41(4)123-79(121)54(30-57(98)44-20-12-15-22-46(44)81)93-77(120)66(39(2)28-62(103)104)94-75(118)55-38-122-78(45-21-14-17-25-56(45)97)96(55)61(102)37-85-69(112)51(32-63(105)106)89-68(111)40(3)86-71(114)52(33-64(107)108)91-70(113)48(24-18-27-80)87-60(101)36-84-76(67)119/h12-17,19-23,25,35,39-41,48-55,66-67,78,83,97H,5-11,18,24,26-34,36-38,80-81H2,1-4H3,(H2,82,99)(H,84,119)(H,85,112)(H,86,114)(H,87,101)(H,88,100)(H,89,111)(H,90,115)(H,91,113)(H,92,116)(H,93,120)(H,94,118)(H,95,117)(H,103,104)(H,105,106)(H,107,108)(H,109,110)/t39-,40-,41-,48+,49+,50-,51+,52+,53+,54+,55+,66+,67+,78?/m1/s1.
What are the key properties of (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid?
(3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid has a molecular weight of 1724.80 g/mol, XLogP of -3.47, 35 rotatable bonds, 21 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(6S,9R,12S,15S,21S,22R,25S,28S,31S)-25-[2-(2-aminophenyl)-2-oxoethyl]-15-(3-aminopropyl)-6,12-bis(carboxymethyl)-28-[(2R)-1-carboxypropan-2-yl]-34-(2-hydroxyphenyl)-9,22-dimethyl-2,5,8,11,14,17,20,24,27,30-decaoxo-23,33-dioxa-1,4,7,10,13,16,19,26,29-nonazabicyclo[29.3.0]tetratriacontan-21-yl]amino]-4-oxobutanoic acid is sourced from PubChem (CID 118054343), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).